African American
|
Caucasian
|
---|
Up-regulated
|
Down-regulated
|
Up-regulated
|
Up-regulated
|
---|
Gene name
|
Fold*
|
Gene name
|
Fold*
|
Gene name
|
Fold*
|
Gene name
|
Fold*
|
---|
IRX5
|
1.9
|
HLA-DQA1
|
-2.4
|
OLFM4
|
1.9
|
DDX3Y
|
-3.1
|
THC2540257
|
1.8
|
MED18
|
-2.3
|
ENST00000382691
|
1.8
|
IFI27
|
-2.5
|
THC2521898
|
1.8
|
THC2667190
|
-1.8
|
CEACAM8
|
1.6
|
DB160230
|
-2.4
|
WDR49
|
1.8
|
GNL3L
|
-1.8
|
WIF1
|
1.6
|
CYorf15B
|
-2.4
|
RNF150
|
1.8
|
CENPI
|
-1.8
|
AI796347
|
1.6
|
BTNL8
|
-2.3
|
AK095945
|
1.8
|
RNF125
|
-1.7
|
HLA-DQA2
|
1.6
|
EGR1
|
-2.3
|
AA579646
|
1.8
|
BU627449
|
-1.7
|
W60781
|
1.5
|
BQ213856
|
-2.1
|
THC2576067
|
1.7
|
ITIH5
|
-1.7
|
OR51B2
|
1.5
|
EGR2
|
-2.0
|
BQ934520
|
1.7
|
AK097130
|
-1.7
|
A_32_P58705
|
1.5
|
SIGLEC1
|
-1.9
|
A_24_P533990
|
1.7
|
ATM
|
-1.7
|
CPSF2
|
1.5
|
IFIT1
|
-1.8
|
- * Fold was the ratio of T2D patient to control in each group. The differences in all listed genes.
- between T2D patients and controls were <0.05.